1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Germany Pharmaceuticals and Healthcare Report Q2 2016

Germany Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 101 pages

Includes 3 FREE quarterly updates

BMI View: Germany's macroeconomic environment will continue to be favourable for drugmakers andhealthcare operators through 2016. Buoyant private consumption and higher public expenditure, broughtabout by migrant/refugee accommodation and social security payments, will appeal to multinationaldrugmakers. Furthermore, in order to mitigate Germany's dire demographics and growing social securityspending brought about by an ageing population, there has been a broader trend in the introduction ofnovel and costly therapies in Germany, leading us to revise upwards our pharmaceuticals market forecastfor 2016.

Headline Expenditure Projections

- Pharmaceuticals: EUR46.50bn (USD51.15bn) in 2015 to EUR47.10bn (USD50.40bn) in 2016; 1.3% inlocal currency terms and -1.5% in US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: EUR326.08bn (USD358.69bn) in 2015 to EUR335.11bn (USD358.56bn) in 2016; +2.8% inlocal currency terms and -0.04% in US dollar terms. Forecast broadly in line with last quarter.

Table Of Contents

Germany Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Germany 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Germany 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 19
Table: Retail Pharmaceutical Expenditure, 2003-2010 (EURbn) 19
Table: Retail Pharmaceutical Expenditure, 2003-2010 (Packages, ms) 20
Table: Retail Pharmaceutical Expenditure, 2003-2010 (Average Price per Pack, EUR) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 23
Generic Medicine Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 26
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Germany 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Germany 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Germany 2014-2020) 31
Pharmaceuticals Risk/Reward Index 32
Western Europe Risk/Reward Index 32
Germany Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Regime 41
Pricing Regime 42
Reimbursement Regime 46
Market Overview 48
Healthcare Sector 48
Table: Healthcare Resources (Germany 2010-2015) 51
Table: Healthcare Personnel (Germany 2010-2015) 51
Table: Healthcare Activity (Germany 2010-2015) 52
Research and Development 52
Clinical Trials 58
Epidemiology 59
Competitive Landscape 61
Research-Based Industry 61
Table: Multinational Market Activity 63
Pharmaceutical Distribution 64
Pharmaceutical Retail Sector 64
Company Profile 66
Bayer Health Care 66
Boehringer Ingelheim 71
GlaxoSmithKline (GSK) 76
Merck KGaA 79
Pfizer 83
STADA Arzneimittel 86
Demographic Forecast 90
Demographic Outlook 90
Table: Population Headline Indicators (Germany 1990-2025) 91
Table: Key Population Ratios (Germany 1990-2025) 91
Table: Urban/Rural Population and Life Expectancy (Germany 1990-2025) 92
Table: Population By Age Group (Germany 1990-2025) 92
Table: Population By Age Group % (Germany 1990-2025) 93
Glossary 95
Methodology 97
Pharmaceutical Expenditure Forecast Model 97
Healthcare Expenditure Forecast Model 97
Notes On Methodology 98
Risk/Reward Index Methodology 99
Index Overview 100
Table: Pharmaceutical Risk/Reward Index Indicators 100
Indicator Weightings 101

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.